NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$27.43
-1.37% today
Updated 2026-04-29
Market cap
$1.20B
P/E ratio
182.87
P/S ratio
139.23x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$6 – $56
Volume
0.0M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
5.3
Growth
C+6.5
Quality
B9.5
Profitability
A+4.0
Valuation
C4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
$0.68
-97.52%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Profit margin 74.10% — above average
+ ROE 27.10% — strong efficiency
+ Revenue growth 73.90% QoQ
Risks
- Negative free cash flow $-6.74M
- P/E 182.87x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $23.54M | $6.71M | $8.19M | $8.65M | $8.65M |
| Net income | $10.01M | $2.25M | $2.37M | $6.40M | $3.04M |
| EPS | — | — | — | — | $0.15 |
| Free cash flow | $4.45M | $898367.00 | $2.08M | $-6.74M | $-6.74M |
| Profit margin | 42.52% | 33.58% | 28.99% | 74.06% | 74.10% |
Peer comparison
Smart narrative
Anbio Biotechnology Class A Ordinary Shares trades at $27.43. representing a P/E of 182.87x trailing earnings. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $8.65M. with profit margins at 74.10%.
Frequently asked questions
What is Anbio Biotechnology Class A Ordinary Shares's stock price?
Anbio Biotechnology Class A Ordinary Shares (NNNN) trades at $27.43.
Is Anbio Biotechnology Class A Ordinary Shares overvalued?
Smart Value Score 52/100 (Grade C, Hold).
What is the price target of Anbio Biotechnology Class A Ordinary Shares (NNNN)?
The analyst target price is $—, representing NaN% downside from the current price of $27.43.
What is Anbio Biotechnology Class A Ordinary Shares's revenue?
TTM revenue is $8.65M.
Piotroski F-Score?
4/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio139.23x
ROE27.10%
Beta—
50D MA$25.00
200D MA$31.90
Shares out0.04B
Float0.04B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—